• Intra-Cellular Therapies average return on equity for 2023 was -27.68, a 41.38% decline from 2022.
• Intra-Cellular Therapies average return on equity for 2022 was -47.22, a 6.59% decline from 2021.
• Intra-Cellular Therapies average return on equity for 2021 was -44.3, a 15% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.